Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
2.
Sci Rep ; 6: 20842, 2016 Feb 16.
Article in English | MEDLINE | ID: mdl-26880249

ABSTRACT

IGHV polymorphism provides a rich source of humoral immune system diversity. One important example is the IGHV1-69 germline gene where the biased use of alleles that encode the critical CDR-H2 Phe54 (F-alleles) to make broadly neutralizing antibodies (HV1-69-sBnAb) to the influenza A hemagglutinin stem domain has been clearly established. However, whether IGHV1-69 polymorphism can also modulate B cell function and Ab repertoire expression through promoter and copy number (CN) variations has not been reported, nor has whether IGHV1-69 allelic distribution is impacted by ethnicity. Here we studied a cohort of NIH H5N1 vaccinees and demonstrate for the first time the influence of IGHV1-69 polymorphism on V-segment usage, somatic hypermutation and B cell expansion that elucidates the dominance of F-alleles in HV1-69-sBnAbs. We provide evidence that Phe54/Leu54 (F/L) polymorphism correlates with shifted repertoire usage of other IGHV germline genes. In addition, we analyzed ethnically diverse individuals within the 1000 genomes project and discovered marked variations in F- and L- genotypes and CN among the various ethnic groups that may impact HV1-69-sBnAb responses. These results have immediate implications for understanding HV1-69-sBnAb responses at the individual and population level and for the design and implementation of "universal" influenza vaccine.


Subject(s)
Antibodies, Viral/genetics , Antibodies, Viral/immunology , Immunoglobulin Heavy Chains/genetics , Influenza A virus/immunology , Polymorphism, Genetic , Alleles , Antibodies, Neutralizing/genetics , Antibodies, Neutralizing/immunology , B-Lymphocytes/immunology , B-Lymphocytes/metabolism , Gene Dosage , Gene Duplication , Genotype , Humans , Influenza A Virus, H5N1 Subtype/immunology , Influenza Vaccines/immunology , Polymorphism, Single Nucleotide , Regulatory Sequences, Nucleic Acid , Somatic Hypermutation, Immunoglobulin
3.
PLoS Pathog ; 10(5): e1004103, 2014 May.
Article in English | MEDLINE | ID: mdl-24788925

ABSTRACT

Recent studies have shown high usage of the IGHV1-69 germline immunoglobulin gene for influenza hemagglutinin stem-directed broadly-neutralizing antibodies (HV1-69-sBnAbs). Here we show that a major structural solution for these HV1-69-sBnAbs is achieved through a critical triad comprising two CDR-H2 loop anchor residues (a hydrophobic residue at position 53 (Ile or Met) and Phe54), and CDR-H3-Tyr at positions 98±1; together with distinctive V-segment CDR amino acid substitutions that occur in positions sparse in AID/polymerase-η recognition motifs. A semi-synthetic IGHV1-69 phage-display library screen designed to investigate AID/polη restrictions resulted in the isolation of HV1-69-sBnAbs that featured a distinctive Ile52Ser mutation in the CDR-H2 loop, a universal CDR-H3 Tyr at position 98 or 99, and required as little as two additional substitutions for heterosubtypic neutralizing activity. The functional importance of the Ile52Ser mutation was confirmed by mutagenesis and by BCR studies. Structural modeling suggests that substitution of a small amino acid at position 52 (or 52a) facilitates the insertion of CDR-H2 Phe54 and CDR-H3-Tyr into adjacent pockets on the stem. These results support the concept that activation and expansion of a defined subset of IGHV1-69-encoded B cells to produce potent HV1-69-sBnAbs does not necessarily require a heavily diversified V-segment acquired through recycling/reentry into the germinal center; rather, the incorporation of distinctive amino acid substitutions by Phase 2 long-patch error-prone repair of AID-induced mutations or by random non-AID SHM events may be sufficient. We propose that these routes of B cell maturation should be further investigated and exploited as a pathway for HV1-69-sBnAb elicitation by vaccination.


Subject(s)
Antibodies, Neutralizing/metabolism , Epitope Mapping , Hemagglutination, Viral/immunology , Hemagglutinin Glycoproteins, Influenza Virus/immunology , Hemagglutinin Glycoproteins, Influenza Virus/metabolism , Influenza A virus/immunology , Amino Acid Sequence , Amino Acid Substitution , Antibodies, Neutralizing/chemistry , Antibodies, Neutralizing/genetics , Epitopes/chemistry , Epitopes/genetics , Epitopes/metabolism , Hemagglutination, Viral/genetics , Hemagglutinin Glycoproteins, Influenza Virus/chemistry , Humans , Influenza Vaccines/chemistry , Influenza Vaccines/genetics , Influenza Vaccines/metabolism , Models, Molecular , Molecular Sequence Data , Molecular Targeted Therapy , Protein Engineering/methods , Protein Structure, Quaternary , Sequence Homology, Amino Acid
SELECTION OF CITATIONS
SEARCH DETAIL
...